Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.JAMA. 2021 Aug 17; 326(7):589-590.JAMA
Links
MeSH
Pub Type(s)
News
Language
eng
PubMed ID
34319350
Citation
Abbasi, Jennifer. "Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines." JAMA, vol. 326, no. 7, 2021, pp. 589-590.
Abbasi J. Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. JAMA. 2021;326(7):589-590.
Abbasi, J. (2021). Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. JAMA, 326(7), 589-590. https://doi.org/10.1001/jama.2021.12915
Abbasi J. Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines. JAMA. 2021 Aug 17;326(7):589-590. PubMed PMID: 34319350.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
A1 - Abbasi,Jennifer,
PY - 2021/7/29/pubmed
PY - 2021/8/24/medline
PY - 2021/7/28/entrez
SP - 589
EP - 590
JF - JAMA
JO - JAMA
VL - 326
IS - 7
SN - 1538-3598
UR - https://www.unboundmedicine.com/medline/citation/34319350/Überantibodies_From_Recovered_COVID_19_Patients_Could_Spur_New_Therapeutics_and_Vaccines_
L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.12915
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
